Skip to content

Fumigate Tedolidine Combined with Thoracic Paravertebral Block for Multimodal Analgesia in Thoracoscopic Esophagectomy: A Prospective Cohort Study

Fumigate Tedolidine Combined with Thoracic Paravertebral Block for Multimodal Analgesia in Thoracoscopic Esophagectomy: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105774
Enrollment
Unknown
Registered
2025-07-10
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Sponsors

The First Affiliated Hospital of University of Science and Technology of China West (Anhui Provincial Cancer Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age: 60 years old = 4); 5. The patient or his family can understand the research content, voluntarily sign an informed consent form, and be willing to comply with the requirements of the experimental plan.

Exclusion criteria

Exclusion criteria: 1. Those with allergic or contraindications such as benzodiazepines, opioids, cyclopolyphenol, flumasinidone, naloxone, tyglidine fumarate and other drugs and their drug components; 2. Those with severe cardiac, lung and renal insufficiency and combined with multiple chronic diseases that cannot tolerate surgical anesthesia; 3. Those with a history of alcohol abuse, opioid allergy, or a history of abuse of such drugs; 4. Other situations that researchers believe are not suitable for enrollment; 5. There are patients with neurological diseases or surgery recently.

Design outcomes

Primary

MeasureTime frame
Difference in resting/motor pain intensity within 24 hours after surgery;

Secondary

MeasureTime frame
First time to remedy analgesia;Total opioid consumption;Postoperative recovery indicators;Security indicators;

Countries

China

Contacts

Public ContactChaoliang Tang

The First Affiliated Hospital of University of Science and Technology of China

chaolt@ustc.edu.cn+86 138 6677 7142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026